AbbVie All Other Countries — Total long-lived assets increased by 32.1% to $420.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 32.1%, from $318.00M to $420.00M.
An increase indicates capital expansion or investment in secondary geographic markets, whereas a decrease may signal asset impairment or a strategic reduction in geographic footprint.
This metric measures the total book value of non-current, tangible, and intangible assets located in geographic regions...
Comparable to 'Other Geographic' asset disclosures in multinational corporations, where assets are aggregated when they do not meet materiality thresholds for individual country reporting.
abbv_segment_all_other_total_long_lived_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $341.00M | $323.00M | $417.00M | $318.00M | $420.00M |
| QoQ Change | — | -5.3% | +29.1% | -23.7% | +32.1% |
| YoY Change | — | -5.3% | +29.1% | -23.7% | +32.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.